cepi.net - Profile | ThreadSky | a Reddit-style client for Bluesky

Rift Valley fever is a major threat to pastoral communities in sub-Saharan Africa, impacting human health and livestock, with devastating consequences for food security. CEPI funds crucial research to tackle this disease, including vaccine development, disease burden studies & more ⬇️ bit.ly/4cNv3sV

submitted 3 days ago • 0 comments

Rift Valley fever is a major threat to pastoral communities in sub-Saharan Africa, impacting human health and livestock, with devastating consequences for food security. CEPI funds crucial research to tackle this disease, including vaccine development, disease burden studies & more ⬇️ bit.ly/4cNv3sV

submitted 3 days ago • 0 comments

For #WorldImmunizationWeek, take a look at a new collection of explainers from CEPI that answer some of the most commonly searched questions about the vaccine technology behind the immunisations that help to protect vulnerable populations around the world. Explore them in the posts below ⏬

submitted 3 days ago • 1 comment

💡Pioneering new CEPI-funded research is set to investigate a promising vaccine technology designed by VitriVax to remove the need for cold-chain storage and condense multi-dose regimens into a single, controlled-release vaccination⤵️

submitted 4 days ago • 0 comments

The reach of #RiftValley fever is expanding, yet no vaccines are currently approved for human use. We’re looking to change that 👉 cepi.net/rift-valley-...

submitted 5 days ago • 0 comments

We've announced over 30 vaccine development partnerships since our launch in 2017. This includes advancing research against: 🔵 Chikungunya 🔵 COVID-19 🔵 Disease X 🔵 Ebola 🔵 Lassa fever 🔵 MERS 🔵 Mpox 🔵 Nipah 🔵 Rift Valley fever Find out more 👇 cepi.net/priority-pat...

submitted 6 days ago • 0 comments

While the #Lassa virus is endemic in West Africa, disease experts have long been warning of the risk that it will soon begin to spread more widely. Find out how new Lassa vaccine trials in West Africa are boosting global viral defences ➡️ cepi.net/how-new-vacc...

submitted 11 days ago • 0 comments

This is an historic step forward in tackling one of the most pressing challenges of our time – a challenge that can only be overcome effectively through international cooperation.

submitted 12 days ago • 1 comment

The race is on. 🏃‍♂️‍➡️ As part of a “pressure test”, backed by CEPI, scientists at Queensland University have been tasked with crafting a vaccine for the Chapare virus—a haemorrhagic fever—in just 150 days, under conditions akin to the time pressure of a real pandemic. 🔬 www.uq.edu.au/news/article...

submitted 12 days ago • 1 comment

The approval of Valneva's CEPI-supported #Chikungunya vaccine by the Brazilian Health Regulatory Agency is a crucial milestone toward making the vaccine available in countries in the Global South where the disease is endemic. valneva.com/press-releas...

submitted 13 days ago • 1 comment

Could disease-fighting antigens produced in a type of fungus accelerate development of protein-based vaccines? cepi.net/exploiting-f...

submitted 14 days ago • 0 comments

🦠 Lassa fever virus was first identified in 1969 in Nigeria. 📍 Cases occur regularly in West Africa. 📈 It is estimated to cause 100000 – 300000 cases annually. Find out how CEPI and its partners are working to help combat this threat ➡️ cepi.net/lassa-fever

submitted 17 days ago • 0 comments

Ensuring strong biosecurity and biosafety is key to tackling emerging epidemic and pandemic threats, whether they arise naturally, accidentally or through deliberate misuse. Find out how CEPI is working collaboratively to strengthen global biosecurity efforts ⬇️ cepi.net/biosecurity

submitted 18 days ago • 0 comments

The Paramyxoviruses contain several prolific viral offenders, including measles, one of the world's most contagious human viruses, and Nipah virus, one of the world's most deadly viruses. Learn more about the Paramyxoviruses in #TheViralMostWanted 🔎 cepi.net/paramyxoviru...

submitted 20 days ago • 0 comments

It was a pleasure to host the @cepi.net Investors Council at our new Seattle office this week! Among the projects discussed was the Research Preparedness Program in East & Central Africa, which aims to bolster regional clinical trial capacity + #EpidemicPreparedness. 👉 bit.ly/3RADeih

submitted 25 days ago • 0 comments

“The threat of coronavirus spillovers is expected to continue and may even intensify in coming years,” says CEPI’s Dr Nadia Cohen. That's why CEPI invests in next-generation coronavirus vaccines to help the world stay ahead. Learn more in @gavi.org's #VaccinesWork blog ⬇️ bit.ly/3FTY2yP

submitted 25 days ago • 0 comments

Could this vaccine approach help overcome our current real-life game of variant ‘whack-a-mole’?💡 CEPI is providing up to $5m to Centivax to advance their tech aiming to create a single-shot vaccine to protect against multiple viruses and their variants: cepi.net/pioneering-v...

submitted 26 days ago • 0 comments

CEPI and PATH are teaming up for the $3.5 million Research Preparedness Program in East and Central Africa, working with regional stakeholders, like Africa CDC, to bolster existing local clinical research capacity and disease outbreak readiness⬇️ cepi.net/boosting-adv...

submitted 27 days ago • 0 comments

#ISNTDFestival 2025 is here and we are delighted to host our next #Books Panel! Don't miss Vivianne Ihekweazu (Nigeria Health Watch), @katekelland.bsky.social @cepi.net & Jonathan Kennedy discussing how pathogens have shaped our lives! 👉Apr 3, 10.15 UK time 👉https://www.isntd.org/isntd-festival

submitted 27 days ago • 0 comments

Check out CEPI's March newsletter 🗞️ In it, we reflect on the 5-year mark since COVID-19 was recognised as a pandemic, and how CEPI and its partners are strengthening global preparedness for future outbreaks. It also spotlights CEPI's latest investments & more. www.linkedin.com/pulse/covid-...

submitted 28 days ago • 0 comments

CEPI, Gennova team up to advance the development of a vaccine candidate against #Nipah virus using self-amplifying mRNA. The project is worth up US$13.38 m. Gennova will also use cutting-edge #AI tech to identify potential Nipah vaccine targets. Find out more 🔬 cepi.net/ai-enhanced-...

submitted 28 days ago • 0 comments

"Lassa fever is an old disease, much neglected" says our Senior Epidemiologist Henshaw Mandi in an interview with @bbcafrica.bsky.social. As one of the world's leading funders of Lassa fever research, CEPI is working with its partners to combat this growing threat.

submitted 31 days ago • 0 comments

Could a type of antibody found in animals like aplacas usher in a new era of affordable antibody-driven infectious disease prevention solutions? This new telegraphnews.bsky.social article explores CEPI's new project with AstraZeneca, which is hoping to answer exactly that question ⬇️ bit.ly/4j2W1yq

submitted 32 days ago • 0 comments

CEPI welcomes @ukhsa.bsky.social's new Priority Pathogens reference tool, which includes 24 viral families of epidemic or pandemic concern (bit.ly/3RjB1Yr). With many viruses able to cause human disease, a tool like this helps determine research priorities and advance preparedness.

submitted 33 days ago • 0 comments

📣Efforts to advance the first-ever vaccine against the deadly Middle East Respiratory Syndrome are progressing, with a new CEPI investment moving a promising vaccine candidate created by Uvax Bio into preclinical trials.

submitted 35 days ago • 0 comments

Did you know that antibodies found in the blood of someone who has fought off a virus can provide key insight into how to protect others from the same virus by guiding optimum vaccine development? Find out how in our new blog ⬇️ cepi.net/how-disease-...

submitted 38 days ago • 0 comments

CEPI, AstraZeneca announce deal to develop novel antibody The novel antibody that could reduce costs and improve access to monoclonal antibody treatments. www.cidrap.umn.edu/m...

submitted 38 days ago • 0 comments

CEPI is providing $43.5 million to @astrazeneca.bsky.social to advance research into an innovative antibody—found in animals like camels & llamas—which could reduce costs & increase global access to antibody-based interventions, compared to existing monoclonal antibodies. cepi.net/cepi-and-ast...

submitted 39 days ago • 0 comments